Ruba Y. Taha

660 total citations
40 papers, 331 citations indexed

About

Ruba Y. Taha is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Ruba Y. Taha has authored 40 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Oncology and 10 papers in Hematology. Recurrent topics in Ruba Y. Taha's work include Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Ruba Y. Taha is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Ruba Y. Taha collaborates with scholars based in Qatar, Egypt and United States. Ruba Y. Taha's co-authors include Halima El Omri, Saba Hasan, Adel Elomri, Abdelfatteh El Omri, Gavin J. Murphy, Matthew S. Metcalfe, M L Nicholson, Regina Padmanabhan, Sabah Akhtar and Maysaloun Merhi and has published in prestigious journals such as SHILAP Revista de lepidopterología, British journal of surgery and International Journal of Environmental Research and Public Health.

In The Last Decade

Ruba Y. Taha

34 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruba Y. Taha Qatar 10 97 67 44 44 42 40 331
Halima El Omri Qatar 10 136 1.4× 75 1.1× 30 0.7× 47 1.1× 49 1.2× 47 355
Nikola Kotur Serbia 16 119 1.2× 48 0.7× 40 0.9× 49 1.1× 12 0.3× 42 453
Pascal Chanu France 13 68 0.7× 137 2.0× 35 0.8× 33 0.8× 15 0.4× 29 403
Pampa Ch Toi India 9 40 0.4× 41 0.6× 45 1.0× 19 0.4× 11 0.3× 41 284
I. Jensen United States 12 156 1.6× 53 0.8× 19 0.4× 41 0.9× 27 0.6× 45 510
Jaqueline de Azevêdo Silva Brazil 12 148 1.5× 33 0.5× 54 1.2× 11 0.3× 19 0.5× 27 410
J. O’Shaughnessy United States 9 183 1.9× 149 2.2× 24 0.5× 50 1.1× 51 1.2× 11 512
Dominika Szőke Italy 11 94 1.0× 51 0.8× 25 0.6× 22 0.5× 9 0.2× 33 428

Countries citing papers authored by Ruba Y. Taha

Since Specialization
Citations

This map shows the geographic impact of Ruba Y. Taha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruba Y. Taha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruba Y. Taha more than expected).

Fields of papers citing papers by Ruba Y. Taha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruba Y. Taha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruba Y. Taha. The network helps show where Ruba Y. Taha may publish in the future.

Co-authorship network of co-authors of Ruba Y. Taha

This figure shows the co-authorship network connecting the top 25 collaborators of Ruba Y. Taha. A scholar is included among the top collaborators of Ruba Y. Taha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruba Y. Taha. Ruba Y. Taha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Omri, Halima El, et al.. (2024). Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review. Frontiers in Oncology. 14. 1390747–1390747. 1 indexed citations
3.
4.
Taha, Ruba Y., et al.. (2024). Successful eradication of acquired factor VIII inhibitors with rituximab: a report of two cases. Hematology. 29(1). 2424521–2424521.
5.
Soliman, Dina Sameh, et al.. (2024). Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes. Cancer Reports. 7(7). e2106–e2106. 1 indexed citations
6.
Padmanabhan, Regina, et al.. (2023). An Artificial Intelligence-Based Diagnostic System for Acute Lymphoblastic Leukemia Detection. Studies in health technology and informatics. 305. 265–268. 4 indexed citations
7.
Taha, Ruba Y., et al.. (2023). Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report. OncoTargets and Therapy. Volume 16. 133–139.
8.
Elomri, Adel, Laoucine Kerbache, Abdelfatteh El Omri, et al.. (2022). Bibliometric analysis of cancer care operations management: current status, developments, and future directions. Health Care Management Science. 25(1). 166–185. 16 indexed citations
9.
Soliman, Dina Sameh, et al.. (2021). Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival. Mediterranean Journal of Hematology and Infectious Diseases. 13(1). e2021043–e2021043. 3 indexed citations
10.
Taha, Ruba Y., et al.. (2021). Neurolymphomatosis of the median nerve, optic nerve, L4 spinal nerve root and cauda equina in patients with B-cell malignancies: a case series. Journal of Medical Case Reports. 15(1). 133–133. 4 indexed citations
11.
Taha, Ruba Y., et al.. (2020). Outcome of six patients with COVID-19 infection and Multiple Myeloma. A Case Series and Literature Review. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020082–e2020082.
12.
Omri, Halima El, Ruba Y. Taha, Adel Elomri, et al.. (2020). Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes. Frontiers in Genetics. 11. 553–553. 5 indexed citations
13.
Akhtar, Sabah, Iman W. Achkar, Kodappully Sivaraman Siveen, et al.. (2019). Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling. Frontiers in Oncology. 9. 285–285. 36 indexed citations
14.
15.
Hasan, Saba, Ruba Y. Taha, & Halima El Omri. (2018). Current Opinions on Chemoresistance: An Overview. Bioinformation. 14(2). 80–85. 49 indexed citations
16.
Omri, Halima El, et al.. (2015). Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases. SHILAP Revista de lepidopterología. 8. CMBD.S25326–CMBD.S25326. 9 indexed citations
17.
Taha, Ruba Y., et al.. (2010). Two Ocular Infections during Conventional Chemotherapy in a Patient with Acute Lymphoblastic Leukemia: A Case Report. Case Reports in Oncology. 3(2). 234–239. 5 indexed citations
18.
El‐Menyar, Ayman, et al.. (2005). Epidemiology of Idiopathic Cardiomyopathy in Qatar during 1996–2003. Medical Principles and Practice. 15(1). 56–61. 6 indexed citations
19.
Soub, Hussam Al, et al.. (2004). Pneumocystis carinii Pneumonia in a patient without a predisposing illness: Case report and review. Scandinavian Journal of Infectious Diseases. 36(8). 618–621. 7 indexed citations
20.
Taha, Ruba Y., Sharon White, T. Horsburgh, & Michael L. Nicholson. (2000). Antithrombotic effects of aspirin after renal transplantation. Transplantation Proceedings. 32(3). 550–550. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halima El Omri Breakdown of academic impact, for papers by Nikola Kotur Breakdown of academic impact, for papers by Pascal Chanu Breakdown of academic impact, for papers by Pampa Ch Toi Breakdown of academic impact, for papers by I. Jensen Breakdown of academic impact, for papers by Jaqueline de Azevêdo Silva Breakdown of academic impact, for papers by J. O’Shaughnessy Breakdown of academic impact, for papers by Dominika Szőke
Rankless by CCL
2026